Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion

NCT01123564 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Retinal Vein Occlusion
Macular Edema

Interventions

DRUG: ranibizumab
RADIATION: Argon laser treatment

Sponsor

University of Pecs

Collaborators

[object Object]